Latest News

How Vaccine Trials Could be Affected by Potential Policy Changes
How Vaccine Trials Could be Affected by Potential Policy Changes

May 8th 2025

In this video interview, Krinx Kong, chief commercial officer, Cognivia, discusses how trial design and timelines could be impacted by a potential mandate for placebo use across all vaccine trials.

© Pixel-Shot - © Pixel-Shot - stock.adobe.com
Boehringer Announces Start of Phase II Geographic Atrophy Trial of Potential First-in-Class Therapy

May 8th 2025

Credit: syahrir | stock.adobe.com
Iqirvo Shows Significant Fatigue Improvement in Patients with Primary Biliary Cholangitis After 52 Weeks in Phase III ELATIVE Trial

May 8th 2025

© photon_photo - © photon_photo - stock.adobe.com
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus

May 7th 2025

Unifying Industry to Better Understand GCP Guidance
Unifying Industry to Better Understand GCP Guidance

May 7th 2025

Applied Clinical Trials April 2025

Check out the latest features and columns!

Check out the latest features and columns!

Conference Coverage

View All
© Egor - © Egor - stock.adobe.com
Notable Discussions from SCOPE 2025: Aiming to Calculate, Accommodate, and Innovate for Enhanced Drug Development

March 11th 2025

Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey
Set the Course for a More Engaging & Productive Patient & Clinical Trial Site Journey

February 26th 2025

SCOPE Summit 2025: Shakthi Kumar Talks Real-World Data Use in Clinical Development
SCOPE Summit 2025: Shakthi Kumar Talks Real-World Data Use in Clinical Development

February 24th 2025

SCOPE Summit 2025: Graham Clark on Ensuring Data Consitency Amid the Rise of Real-World Evidence
SCOPE Summit 2025: Graham Clark on Ensuring Data Consitency Amid the Rise of Real-World Evidence

February 21st 2025

Latest Videos
Podcasts

All News

© 2025 MJH Life Sciences

All rights reserved.